Zhejiang CONBA Pharmaceutical Co Ltd (600572) — Free Cash Flow Generation Index
Zhejiang CONBA Pharmaceutical Co Ltd (600572) has a Free Cash Flow Generation Index of 0.80x as of September 2025. Free cash flow of CN¥106.53 Million represents 1% of operating cash flow (CN¥133.43 Million). Read total liabilities of Zhejiang CONBA Pharmaceutical Co Ltd for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Zhejiang CONBA Pharmaceutical Co Ltd Free Cash Flow Generation Index (2003–2025)
Historical FCF Generation Index trend for Zhejiang CONBA Pharmaceutical Co Ltd across 23 annual periods. Explore capital reinvestment ratio of Zhejiang CONBA Pharmaceutical Co Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Zhejiang CONBA Pharmaceutical Co Ltd (2003–2025)
Year-by-year Free Cash Flow Generation Index for Zhejiang CONBA Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see how much is Zhejiang CONBA Pharmaceutical Co Ltd worth.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.84x | CN¥795.35 Million | CN¥942.61 Million | CN¥147.26 Million | ▲ +18.3% |
| 2024 | 0.71x | CN¥721.90 Million | CN¥1.01 Billion | CN¥290.63 Million | ▼ -7.1% |
| 2023 | 0.77x | CN¥689.50 Million | CN¥898.64 Million | CN¥209.14 Million | ▲ +2.6% |
| 2022 | 0.75x | CN¥863.73 Million | CN¥1.16 Billion | CN¥291.75 Million | ▲ +106.9% |
| 2021 | 0.36x | CN¥321.56 Million | CN¥889.94 Million | CN¥568.37 Million | ▼ -42.8% |
| 2020 | 0.63x | CN¥789.30 Million | CN¥1.25 Billion | CN¥460.40 Million | ▼ -11.0% |
| 2019 | 0.71x | CN¥656.71 Million | CN¥925.50 Million | CN¥268.79 Million | ▲ +133.1% |
| 2018 | 0.30x | CN¥166.15 Million | CN¥545.78 Million | CN¥379.63 Million | ▼ -48.4% |
| 2017 | 0.59x | CN¥420.47 Million | CN¥712.27 Million | CN¥291.80 Million | ▼ -22.4% |
| 2016 | 0.76x | CN¥737.88 Million | CN¥969.71 Million | CN¥231.83 Million | ▲ +16.2% |
| 2015 | 0.65x | CN¥544.29 Million | CN¥831.26 Million | CN¥286.97 Million | ▲ +114.8% |
| 2014 | 0.30x | CN¥188.20 Million | CN¥617.43 Million | CN¥429.23 Million | ▲ +129.8% |
| 2013 | -1.02x | CN¥-240.97 Million | CN¥235.36 Million | CN¥476.32 Million | ▼ -4293.4% |
| 2012 | 0.02x | CN¥6.00 Million | CN¥245.76 Million | CN¥239.76 Million | ▼ -91.7% |
| 2011 | 0.29x | CN¥55.27 Million | CN¥188.36 Million | CN¥133.09 Million | ▲ +187.4% |
| 2010 | 0.10x | CN¥12.86 Million | CN¥125.93 Million | CN¥113.07 Million | ▼ -84.3% |
| 2009 | 0.65x | CN¥100.07 Million | CN¥153.39 Million | CN¥53.32 Million | ▲ +268.8% |
| 2008 | 0.18x | CN¥17.44 Million | CN¥98.56 Million | CN¥81.12 Million | ▲ +868.2% |
| 2007 | -0.02x | CN¥-1.84 Million | CN¥79.98 Million | CN¥81.83 Million | ▼ -129.7% |
| 2006 | 0.08x | CN¥5.53 Million | CN¥71.20 Million | CN¥65.67 Million | ▲ +748.3% |
| 2005 | 0.01x | CN¥1.08 Million | CN¥117.65 Million | CN¥116.57 Million | ▼ -64.0% |
| 2004 | 0.03x | CN¥1.66 Million | CN¥65.47 Million | CN¥63.81 Million | ▼ -93.6% |
| 2003 | 0.39x | CN¥26.30 Million | CN¥66.64 Million | CN¥40.34 Million | — |